Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Work In Process (2016 - 2020)

Historic Work In Process for Trinity Biotech (TRIB) over the last 5 years, with Q4 2020 value amounting to $5.2 million.

  • Trinity Biotech's Work In Process fell 2551.87% to $5.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $5.2 million, marking a year-over-year decrease of 2551.87%. This contributed to the annual value of $5.2 million for FY2020, which is 2551.87% down from last year.
  • As of Q4 2020, Trinity Biotech's Work In Process stood at $5.2 million, which was down 2551.87% from $6.9 million recorded in Q4 2019.
  • Trinity Biotech's 5-year Work In Process high stood at $8.2 million for Q4 2018, and its period low was $5.2 million during Q4 2020.
  • In the last 5 years, Trinity Biotech's Work In Process had a median value of $7.2 million in 2017 and averaged $7.0 million.
  • Per our database at Business Quant, Trinity Biotech's Work In Process surged by 1386.12% in 2018 and then tumbled by 2551.87% in 2020.
  • Trinity Biotech's Work In Process (Quarter) stood at $7.3 million in 2016, then decreased by 0.71% to $7.2 million in 2017, then increased by 13.86% to $8.2 million in 2018, then decreased by 15.77% to $6.9 million in 2019, then dropped by 25.52% to $5.2 million in 2020.
  • Its last three reported values are $5.2 million in Q4 2020, $6.9 million for Q4 2019, and $8.2 million during Q4 2018.